Creative Medical Technology Holdings, Inc. Cash and Restricted Cash
Creative Medical Technology Holdings, Inc. (CELZ) had Cash and Restricted Cash of $8.71 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.71M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.72M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.21M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.38M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $8.71M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $5.72M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $7.21M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $5.38M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $6.55M 10-Q · filed 2026-08-07 | $6.54M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $7.70M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $5.94M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $6.26M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $7.47M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $9.01M 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $3.47M 10-K · filed 2026-03-20 | |
| 2023-09-30 | $4.51M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $3.99M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $9.52M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $8.32M 10-K · filed 2025-03-14 | |
| 2022-09-30 | $16.97M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $22.86M 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $9.15M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $10.72M 10-K · filed 2024-03-22 | |
| 2021-09-30 | $2.38M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $98.01K 10-K · filed 2023-03-31 | |
| 2020-03-31 | $38.33K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $88.65K 10-Q · filed 2020-05-15 | |
| 2019-09-30 | $158.24K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $204.11K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $419.48K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $304.06K 10-Q · filed 2020-05-15 | |
| 2018-09-30 | $172.83K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $100.50K 10-Q · filed 2019-08-13 | |
| 2017-12-31 | $13.70K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |